000 05553cam a2200409Mi 4500
001 95163
003 ES-MaUEC
005 20230102112650.0
006 m o d
007 cr |||||||||||
008 170104s2017 sz o 001 0 eng d
020 _a3319469525
_q(electronic bk.)
020 _a9783319469522
_q(electronic bk.)
020 _z3319469509
020 _z9783319469508
035 _a(OCoLC)967850086
_z(OCoLC)967656002
_z(OCoLC)967683632
_z(OCoLC)970610689
_z(OCoLC)974649569
_z(OCoLC)981018906
_z(OCoLC)1005809255
_z(OCoLC)1011793381
040 _aIDEBK
_cIDEBK
_dEBLCP
_dN$T
_dGW5XE
_dN$T
_dYDX
_dAZU
_dUAB
_dCOO
_dUPM
_dOCLCF
_dOCLCO
_dIOG
_dOCLCO
_dVT2
_dMERER
_dESU
_dOCLCQ
_dOCLCO
_dJBG
_dIAD
_dOCLCO
_dIDEBK
_dICW
_dOCLCO
_dICN
_dILO
_dOCLCO
_dOTZ
_dOCLCQ
_dOCLCO
_dOCLCQ
_dOCLCO
_dU3W
_dES-MaUEC
_bspa
050 4 _aRD123.5
_b2017 EB
245 0 0 _aAtlas of graft-versus-host disease :
_bapproaches to diagnosis and treatment
_cJonathan A. Cotliar, editor.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aForeword; Preface; Contents; Contributors; 1: Overview of€Hematopoietic Cell Transplantation; Historical Perspective; Indications for€Allogeneic Hematopoietic Cell Transplantation; Sources of€Hematopoietic Stem Cells; Peripheral Blood Mobilized Stem Cells; Bone Marrow Hematopoietic Stem Cells; Umbilical Cord Blood Stem Cells; Stem Cell Donors; Matched Related Donor; Matched Unrelated Donor; Haploidentical Stem Cell Donors; Conditioning Regimens; Myeloablative Regimens; Reduced-Intensity Conditioning; Graft-Versus-Host Disease Prophylaxis and€Treatment; Prophylaxis.
505 8 _a6: Grading and€Treatment of€Acute Graft-ƯVersus-ƯHost Disease Diagnosis and€Grading of€aGVHD; Physiology Overview; Diagnosis; Differential Diagnosis; Drug Hypersensitivity; Toxic Erythema of€Chemotherapy; Engraftment Syndrome; Grading and€Prognostication; Treatment of€aGVHD; Brief Note on€the€Prevention of€aGVHD; Treatment of€Grade I€aGVHD; Grade II or Greater aGVHD; Corticosteroid-Refractory aGVHD; Extracorporeal Photopheresis; Anti-CD26 Antibody; Rabbit Antithymocyte Globulin; References.
505 8 _aHistologic Grading and€Microscopic Findings Clues to€Histologic Diagnosis; Differential Diagnosis of€Acute GVHD; Potential Adjunctive Tests; Special Situations; Chronic Graft-Versus-Host-Disease; Main Histologic Patterns in€cGVHD: Lichenoid and€Sclerodermoid; Unique Histologic Features of€cGVHD; Psoriasiform Pattern; Eczematous Pattern; Lupus-like Pattern; Pityriasis Rosea-like Pattern; Comedone-like Pattern; Follicular Keratosis or Keratosis Pilaris-like Pattern; cGVHD-associated Angiomatosis; Differential Diagnosis of€cGVHD; References.
505 8 _aInflammatory Cytokine Biomarkers Genetic Polymorphism; References; 3: Clinical Presentation of€Acute Cutaneous Graft-Versus-Host Disease; Diagnosing and€Staging/Grading Acute€GVHD; Clinical Manifestations of€Acute GVHD; Erythema; Follicular Accentuation; Morbilliform Lesions; Erythroderma; Reticulated Patterns; Desquamation; Bullae; Papules; References; 4: Clinical Presentation of€Mucosal Acute and€Chronic Graft-Versus-Host Disease; References; 5: Histopathology of€Cutaneous Graft-ƯVersus-ƯHost Disease; Acute Graft-Versus-Host Disease; Concept of€Interface Dermatitis.
505 8 _aTreatment of€Acute GVHD Chronic GVHD; Risk Factors Associated with€Chronic GVHD; Treatment of€Chronic GVHD; Causes of€Treatment Failure; Supportive Care; References; 2: Pathophysiology and€Immunology of€Chronic Graft-Versus-Host Disease; Basic Biology of€cGVHD; cGVHD Biomarker; Cellular Biomarkers; T Cells; T-Cell Differentiation Status; CD4 T-Cell Cytokine Subsets (Th1, Th2, Th 17); Regulatory T Cells (Tregs); Antigen-Presenting Cells; B Cells and€Humoral Immunity; B Cell and€B-Cell Activating Factor (BAFF); Auto-antibodies; Allo-antibodies; Natural Killer (NK) Cells.
520 3 _aThis atlas provides valuable guidance for medical students, residents, fellows, nurses, attending physicians, and other allied health professionals taking care of patients with graft-versus-host disease (GVHD). Our understanding about the intricacies of GVHD diagnosis and treatment are constantly developing as basic and translational science in the field evolves. As such, this text reflects the best current evidence we have to date for clinicians treating patients with GVHD. The Atlas of Graft-versus-Host Disease is a concise and useful graphical resource providing comprehensive guidance required for a disease entity that has a heterogeneous and complicated clinical presentation. It has been written with input of both oncologists and dermatologists, which has enabled the capture of perspectives and nuances of GVHD diagnosis and management that can influence readers with varied training backgrounds and current clinical practice, thus creating a powerful and useful resource for readers.
650 7 _aCáncer
_xCirugía
_2embne
_0(OCoLC)fst00845532
_0
_9175031
700 1 _aCotliar, Jonathan A.
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-46952-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c95163
_d95163
_x1